Поиск биологических маркеров дизрегуляционных нарушений при детском церебральном параличе

21. Morgun A. V., Ovcharenko N. V., Taranushenko T. E., Ustinova S. I., Okuneva O. S., Antonova S. K., Gilyazova D. F., Uspenskaya O. A., Salmina A. B. Markery apoptoza i neyrospetsificheskie belki v diagnostike perina- tal'nykh porazheniy tsentral'noy nervnoy sistemy u novorozhdennykh detey [Markers of apoptosis and neurospecific proteins in the diagnosis of perinatal lesions of central nervous system in newborns]. Sibirskoe meditsinskoe obozrenie. [Siberian Medical Review], 2013, no. 3 (81), pp. 3-11.

22. Morozova A. A., Pinyaev S. I., Revina E. S. Osobennosti belkovogo sostava mielinovoy obolochki i osevykh tsilindrov aksonov perifericheskogo nerva v norme i pri povrezhdenii [Features of the protein composition of the myelin sheath and axial cylinders of the axons of the peripheral nerve are normal and with damage]. Materialy nauchnoy konferentsii “XLIV Ogarevskie chteniya” v 3 chastyakh. Chast' 2. Estestvennye nauki [Materials of scientific conference “XLIV Ogarev readings” in 3 parts. Part 2. Natural sciences. Saransk, December 8-15, 2015). Saransk, Mordovian University Press, 2016, pp. 206-211.

23. Nurzhanova Z. M., Bashkina O. A., Samotrueva M. A. Komorbidnaya patologiya pri detskom tserebral'nom paraliche i osobennosti reabilitatsionnogo protsessa [Comorbid pathology in infantile cerebral palsy and features of the rehabilitation process]. Astrakhanskiy meditsinskiy zhurnal [Astrakhan Medical Journal], 2019, vol. 14, no. 1, pp. 27-38.

24. Panova M. S., Panchenko A. S. Rol' tsitokinov i ikh geneticheskogo polimorfizma v razvitii gipoksicheski- ishemicheskoy entsefalopatii u donoshennykh novorozhdennykh detey [The role of cytokines and their genetic polymorphism in the development of hypoxic- ischemic encephalopathy among full-term newborn children]. Pediatr [Pediatr], 2017, vol. 8, no. 6, pp. 99-104.

25. Petrova N. N., Butoma B. G. Sovremennye biologicheskie metody diagnostiki psikhicheskikh rasstroystv [Modern biological methods for the diagnosis of mental disorders]. Moscow, Izdatel'skiy tsentr “Akademiya” [Publishing house “Academia”], 2015, 189 p.

26. Preobrazhenskaya I. S., Chekhonin V. P., Yakhno N. N. Pronitsaemost' gematoentsefalicheskogo bar'era pri bolezni Al'tsgeymera i parkinsonizme s kognitivnymi narusheniyami [Permeability of the blood-brain barrier in Alzheimer's disease and Parkinsonism with cognitive impairment]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [S.S. Korsakov Journal of Neurology and Psychiatry], 2001, vol. 101, no. 5, pp. 23-28.

27. Sakharnova T. A., Vedunova M. V., Mukhina I. V. Neytroficheskiy faktor golovnogo mozga i ego rol' v funktsionirovanii tsentral'noy nervnoy sistemy [Brain-derived neurotrophic factor (BDNF) and its role in the functioning of the central nervous system]. Neyrokhimiya [Neurochemical Journal], 2012, vol. 29, no. 4, pp. 269-277.

28. Svetozarskiy N. L., Artifeksova A. A., Svetozarskiy S. N. Faktor rosta endoteliya sosudov: biologicheskie svoystva i prakticheskoe znachenie (obzor literatury) [Growth promoting factor of endothelium of vessels: biological properties and practical value (literature review)]. Meditsina i obrazovanie v Sibiri [Journal of Siberian Medical Sciences], 2015, no. 5, p. 24.

29. Semenov A. S., Skal'nyy A. V. Immunopatologicheskie i patokhimicheskie aspekty patogeneza perina- tal'nogo porazheniya mozga (detskiy tserebral'nyy paralich, alkogol'nyy sindrom ploda) [ Immunopathological and pathochemical aspects of the pathogenesis of perinatal brain damage (cerebral palsy, fetal alcohol syndrome)]. Saint Petersburg, Nauka, 2009, 368 p.

30. Serkina E. V., Gromova O. A., Torshin I. Yu., Sotnikova N. Yu., Nikonov A. A. Tserebrolizin oblegchaet sostoyanie bol'nykh s perinatal'nym porazheniem TsNS cherez modulyatsiyu autoimmuniteta i antioksidantnuyu zash- chitu [Cerebrolysin alleviates perinatal CNS disorders through the autoimmune modulation and antioxidant protection]. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova [S.S. Korsakov Journal of Neurology and Psychiatry], 2008, vol. 108, no. 11, pp. 62-66.

31. Skvortsov I. A., Ermolenko N. A. Razvitie nervnoy sistemy u detey v norme i patologii [The development of the nervous system in children is normal and pathological]. Moscow, MEDpress-inform [Publishing house “MEDpress- inform”], 2003, 368 p.

32. Skvortsova V. I. Neyroprotektivnaya terapiya ishemicheskogo insul'ta [Neuroprotective therapy for ischemic stroke]. Vrach [The Doctor], 2004, no. 6, pp. 26-32.

33. Sokolova M. G. Neytrofiny-markery reparativno-destruktivnogo protsessa v TsNS u detey, bol'nykh detskim tserebral'nym paralichom [Neurotrophins-markers reparative-destructive processesin children with cerebral palsy]. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I.I. Mechnikova [Herald of NorthWestern State Medical University named after I.I. Mechnikov], 2015, vol. 7, no. 1, pp. 93-96.

34. Tabolin V. A., Volodin N. N., Degtyareva M. V. Aktual'nye voprosy perinatal'noy immunologii [Actual issues of perinatal immunology]. Detskaya immunologiya [Pediatric Immunology], 2004. no. 1. pp. 1-14.

35. Taranushenko T. E., Okuneva O. S., Dem'yanova I. M., Salmina A. B., Malinovskaya N. A., Sharoglazova L. A., Kritskaya I. A., Morgun A. V. Urovni belkov neyronal'noy i glial'noy prirody v krovi novo- rozhdennykh pri tserebral'noy ishemii [Protein levels of neuronal and glial nature in the blood of newborns with cerebral ischemia]. Pediatriya. Zhurnal imeni G.N. Speranskogo [Journal “Pediatria” named after G.N. Speransky], 2010, vol. 89, no. 1, pp. 25-31.

36. Fegyu N., Kozhokar' L. Neyroprotektivnye svoystva opioidnykh peptidov, v chastnosti beta-endorfina, pri nekotorykh autoimmunnykh endokrinopatiyakh [Neuroprotective properties of opioid peptides, in particular beta-endorphin, in some autoimmune endocrinopathies]. Studia Universitatis [Studia Universitatis], 2013, vol. 21, no. 1, pp. 106-110.

37. Tsirkin V. I., Trukhina S. I., Trukhin A. N. Oksitotsin: sintez, vydelenie, metabolizm i regulyatsiya etikh protsessov [Oxytocin: synthesis, release, metabolism and the regulation of these processes]. Zhurnal mediko- biologicheskikh issledovaniy [Journal of Medical and Biological Research], 2018 vol. 6, no. 3, pp. 270-283.

38. Chegodaev D. A., L'vova O. A., Baranov D. A. Geneticheskie aspekty patogeneza detskogo tserebral'nogo paralicha [Cerebral palsy - genetic aspects of pathogenesis]. Sistemnaya integratsiya v zdravookhranenii [System Integration in Health Care], 2012, vol. 17, no. 3, pp. 52-60.

39. Chekhonin V. P., Gurina I. A., Ryabukhin I. A. Immunofermentnyy analiz neyrospetsificheskoyelonazy na osnove monoklonal'nykh antitel v otsenke pronitsaemosti gematoentsefaliticheskogo bar'era pri nervnopsikhicheskikh zabolevaniyakh [Enzyme-linked immunosorbent assay of neuron-specific elonase based on monoclonal antibodies in assessing the permeability of the blood-brain barrier in neuropsychiatric diseases]. Rossiyskiy psikhiatricheskiy zhurnal [Russian Journal of Psychiatry], 2000, no. 4, pp. 15-19.

40. Chekhonin V. P., Semenova A. V., Turina O. I., Dmitrieva T. B. Mielin-oligodendrogliotsitarnyy protein: stroenie, funktsii, rol' v patogeneze demieliniziruyushchikh rasstroystv [ Myelin oligodendrogliocyte glycoprotein the structure, functions, role in pathogenesis of demyelinating diseases]. Biomeditsinskaya khimiya [Biomedical chemistry], 2003, vol. 49, no. 5, pp. 411-423.

41. Chekhonin V. P., Gurina O. V., Dmitrieva T. B., Semenova A. V., Savchenko E. A., Grigor'ev M. E. Osnovnoy belok mielina. Stroenie, svoystva, funktsii, rol' v diagnostike demieliniziruyushchikh zabolevaniy [Myelinbasic protein. Structure, physico-chemical properties, biological function and diagnostic significance for the demyelinating diseases]. Voprosy meditsinskoy khimii [Biomedical chemistry], 2000, vol. 46, no. 6, pp. 549-563.

42. Chekhonin V. P., Lebedev S. V., Blinov D. V., Gurina O. I., Semenova A. V., Lazarenko I. P., Petrov S. V., Ryabukhin I. A., Rogatkin S. O., Volodin N. N. Patogeneticheskaya rol' narusheniya pronitsaemosti gematoentse- falicheskogo bar'era dlya neyrospetsificheskikh belkov pri perinatal'nykh gipoksicheski-ishemicheskikh porazheniyakh tsentral'noy nervnoy sistemy u novorozhdennykh [A pathogenetic role of impaired permeability of the hematoencephalic barrier for neurospecific proteins in perinatal hypoxic-ischemic damages of the central nervous system in neonates]. Voprosy ginekologii, akusherstva i perinatologii [Gynecology, Obstetrics and Perinatology], 2004, vol. 3, no. 2, pp. 50-61.

43. Abbot N. J., Ronnback L., Hansson E. Asrocyte-endotelial interactions at the blood-brain barrier. Nature Reviews. Neuroscience, 2006, vol. 7, no. 1, pp. 41-53.

44. Blennow M., Sдvman K., Ilves P., Thoresen M., Rosengren L. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta paediatrica, 2007, vol. 90, no. 10. pp. 1171-1175.

45. Brouns R., De Vil B., Cras P., De Surgeloose D., Mariлn P., De Deyn P. P. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients. Clinical Chemistry, 2010, vol. 56, no. 3, pp. 451-458.

46. Chan S. J., Love C., Spector M., Cool S. M., Nurcombe V., Lo E. H. Endogenous regeneration: Engineering growth factors for stroke. Neurochemistry International, 2017, vol. 107, pp. 57-65.

47. Clarke M., Newton R. W., Klapper P. E., Sutcliffe H., Laing I., Wallace G. Childhood encephalopathy: viruses, immune response, and outcome. Developmental Medicine Child Neurology, 2006, vol. 48, no. 4, pp. 294-300.

48. Eggers K., Werneburg S., Schertzinger A., Abeln M., Schiff M., Scharenberg M. A., Burkhardt H., Mьhlenhoff M., Hildebrandt H. Polysialic acid controls NCAM signals at cell-cell contacts to regulate focal adhesion independent from FGF receptor activity. J. Cell Sci., 2011, vol. 124, no. 19, pp. 3279-3291.

49. Forgie A., Kuehnel F., Wyatt S., Davies A. M. In vivo survival requirement of a subset of nodose ganglion neurons for nerve growth factor. Eur. J. Neurosci., 2000, vol. 12, no. 2. pp. 670-676.

50. Gruden M. A., Davidova T. B., Malisauskas M., Sewell R. D., Voskresenskaya N. I., Wilhelm K., Elistratova E. I., Sherstnev V. V., Morozova-Roche L. A. Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: Autoantibodies to AЯ(25-35) oligomers, S100b and neurotransmitters. Journal of Neuroimmunology, 2007, vol. 186, no. 1-2, pp. 181-192.

51. Hatton G. I. Glial-neuronal interactions in the mammalian brain. Advances in Physiology Education, 2002, vol. 26, no. 1-4, pp. 225-237.

52. Kar S., Slowikowski S. P., Westaway D., Mount H. T. Interactions between beta-amyloid and central cholinergic neurons: Implications for Alzheimer's disease. Journal of Psychiatry and Neuroscience, 2004, vol. 29, no. 6, pp. 427-441.

53. Kim S. Y., Kim K. M., Hoffman-Kim D., Song H. K., Palmore G. T. Quantitative control of neuron adhesion at a neural interface using a conducting polymer composite with low electrical impedance. ACS Appl. Mater. Interfaces, 2011, vol. 3, no. 1, pp. 16-21.

54. Leibinger M., Andreadaki A., Diekmann H., Fischer D. Neuronal STAT3 activation is essential for CNTF- and inflammatory stimulation-induced CNS axon regeneration. Cell Death Dis., 2013, vol. 4, no. 9, pp. e805.

55. Marchi N., Cavaglia M., Fazio V., Bhudia S., Hallene K., Janigro D. Peripheral markers of blood-brain barrier damage. Clinica Chimica Acta, 2004,vol. 342, no. 1-2, pp. 1-12.

56. Rosenstein J. M., Krum J. M., Ruhrberg C. VEGF in the nervous system. Organogenesis, 2010, vol. 6, no. 2, pp. 107-114.

57. Sдvman K., Blennow M., Hagberg H., Tarkowski E, Thoresen M, Whitelaw A. Cytokine response in cerebrospinal fluid from preterm infants with posthaemorrhagic ventricular dilatation. Acta Paediatr , 2007, vol. 91, no. 12, pp. 1357-1363.

58. Soliman А. М., Al-Gendy R. A., Abdel-Moety H. Hypoxic-ischemig encephalopathy in term neonates: early biochemical indicators. Australian J. Basic and Applied Sci., 2011, vol. 5, no. 5, pp. 82-87.

59. Welch R. D., Ellis M., Lewis L. M., Ayaz S. I., Mika V. H., Millis S., Papa L. Modeling the kinetics of serum glial fibrillary acidic ptotein, ubicuitin carboxyl-terminal hydrolase L1, and S100b concetrations in patients with traumatic brain injury. J. Neurotrauma, 2017, vol. 34. no. 11, pp. 1957-1971.

Размещено на Allbest.ru